Ignite Creation Date:
2025-12-24 @ 2:58 PM
Ignite Modification Date:
2026-02-25 @ 6:52 PM
Study NCT ID:
NCT00554359
Status:
COMPLETED
Last Update Posted:
2011-02-23
First Post:
2007-11-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Dose Escalation and Safety Study of I5NP in Patients Undergoing Major Cardiovascular Surgery
Sponsor:
Quark Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
QRK.002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Mike Johnston, Director of Regulatory Affairs
Old Organization:
Quark Pharmaceuticals, Inc.